Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing NaN - NaN of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Tucson, Arizona
  • +147 more
Jan 24, 2023

Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

Recruiting
  • Carcinoma, Renal Cell
  • Chandler, Arizona
  • +176 more
Jan 19, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Birmingham, Alabama
  • +229 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Nivolumab/Ipilimumab)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab/Ipilimumab
  • Linz, Austria
  • +34 more
Aug 3, 2021

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Huntsville, Alabama
  • +226 more
Apr 19, 2021

Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))

Completed
Has Results
  • Carcinoma, Renal Cell
  • Regorafenib (Stivarga, BAY73-4506)
  • Los Angeles, California
  • +17 more
Jan 27, 2021

Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

Completed
  • Carcinoma, Renal Cell
  • +3 more
  • Ann Arbor, Michigan
  • +8 more
Dec 16, 2020

Carcinoma, Renal Cell Trial in United Kingdom, United States (Pazopanib, MK-3475)

Completed
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +5 more
Feb 28, 2020

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006))

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bordeaux, France
  • +21 more
Nov 23, 2015

Carcinoma, Renal Cell Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Nexavar (Sorafenib, BAY43-9006)
  • Bruxelles - Brussel, Belgium
  • +32 more
Dec 26, 2014

Carcinoma, Renal Cell Trial in United Kingdom, United States (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Chicago, Illinois
  • +6 more
Dec 18, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Sorafenib (Nexavar, BAY43-9006) + Interferon)

Terminated
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Sorafenib (Nexavar, BAY43-9006) + Interferon
  • Salzburg, Austria
  • +34 more
Nov 24, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Interferon)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sacramento, California
  • +41 more
Oct 24, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Tucson, Arizona
  • +120 more
Jan 8, 2014

Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Interferon Alfa
  • +2 more
  • Little Rock, Arkansas
  • +153 more
Sep 24, 2012

Carcinoma, Renal Cell Trial in Worldwide (Sutent)

Approved for marketing
  • Carcinoma, Renal Cell
  • Scottsdale, Arizona
  • +273 more
Mar 8, 2012

Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Jonesboro, Arkansas
  • +123 more
Jan 19, 2010